Cartalax (20mg) Dosage Protocol
Cartalax is a tripeptide from the Khavinson bioregulator series designed to target cartilage and connective tissues. Research suggests it may support joint health and cartilage regeneration.
Add 2.0 mL bacteriostatic water → 10 mg/mL
10-20 mg daily for 10-20 day cycles
At 10 mg/mL: 10 units = 1 mg, 100 units = 10 mg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Days 1-10 | 10 mg daily | 100 units (1.0 mL) |
| Days 11-20 | 10-20 mg daily | 100-200 units |
| Cycle off | 1-3 months | Before repeating |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly into the vial
- 3Gently swirl until fully dissolved
- 4Label with date and concentration, refrigerate immediately
Cartalax targets cartilage and connective tissues through peptide bioregulation. Research suggests it may support chondrocyte function and cartilage matrix production through tissue-specific gene expression modulation.
- Targets cartilage tissues
- May support joint health
- Research suggests connective tissue support
- Part of comprehensive joint protocols
- Khavinson VK, et al. Peptide bioregulators. Bull Exp Biol Med. 2011
- Khavinson musculoskeletal peptide research
- Cartalax cartilage tissue research
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Part of Khavinson musculoskeletal bioregulator series
- •Research compound from Khavinson series
- •Use in short cycles with breaks
- •Often combined with BPC-157 for joints
- •Consult healthcare provider for joint conditions
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.